These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 26520143)

  • 1. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
    Shuang T; Wang M; Zhou Y; Shi C
    Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of nuclear NF-κB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer.
    Shuang T; Wang M; Zhou Y; Shi C
    Exp Mol Pathol; 2016 Feb; 100(1):139-44. PubMed ID: 26683819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.
    Meng Q; Duan P; Li L; Miao Y
    Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic significance of SIRT1 in ovarian epithelial tumours.
    Jang KY; Kim KS; Hwang SH; Kwon KS; Kim KR; Park HS; Park BH; Chung MJ; Kang MJ; Lee DG; Moon WS
    Pathology; 2009; 41(4):366-71. PubMed ID: 19404850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer.
    Hou S; Du P; Wang P; Wang C; Liu P; Liu H
    Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
    Wang M; He Y; Shi L; Shi C
    Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
    Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
    Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA; Sabaa BE; Abdelkhalik D; Mansour H; Melis M; Shaalan W; Farouk M; Malik E; Soliman AA
    J Cancer Res Clin Oncol; 2016 May; 142(5):949-58. PubMed ID: 26762850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.
    Liu P; Wang Y; Tong L; Xu Y; Zhang W; Guo Z; Ni H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1163-71. PubMed ID: 26542279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer.
    Wang Y; Li M; Meng F; Lou G
    Hum Pathol; 2017 Feb; 60():114-120. PubMed ID: 27818289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
    Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J
    Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
    Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
    J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer.
    Mei L; Hu Q; Peng J; Ruan J; Zou J; Huang Q; Liu S; Wang H
    Int J Clin Exp Pathol; 2015; 8(5):5597-602. PubMed ID: 26191270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.